Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients
Lactiga's investors include NJEDA, 1517 Fund, National Institutes of Health, Innovation Factory (Canada), National Institute of Allergy and Infectious Diseases.
Lactiga is headquartered in Princeton, United States.
Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients
Lactiga is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lactiga — Funding & Investors." VCBacked, September 4, 2025, https://www.vcbacked.co/company/lactiga. Accessed July 19, 2026.
VCBacked. (2025). Lactiga — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/lactiga
{{cite web |title=Lactiga — Funding & Investors |url=https://www.vcbacked.co/company/lactiga |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated